Source: http://docplayer.net/17992909-May-7-2015-tactile-systems-technology-inc-daniel-chase-v-p-engineering-operations-1331-tyler-st-ne-minneapolis-minnesota-55413.html
Timestamp: 2020-01-18 05:33:15
Document Index: 421602767

Matched Legal Cases: ['arts 800', 'art 807', 'art 801', 'art 820', 'art 801', 'art 803', 'art 21']

May 7, Tactile Systems Technology Inc Daniel Chase V.P. Engineering & Operations 1331 Tyler St NE Minneapolis, Minnesota PDF Free Download
May 7, Tactile Systems Technology Inc Daniel Chase V.P. Engineering & Operations 1331 Tyler St NE Minneapolis, Minnesota 55413
Download "May 7, 2015. Tactile Systems Technology Inc Daniel Chase V.P. Engineering & Operations 1331 Tyler St NE Minneapolis, Minnesota 55413"
1 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD May 7, 2015 Tactile Systems Technology Inc Daniel Chase V.P. Engineering & Operations 1331 Tyler St NE Minneapolis, Minnesota Re: K Trade/Device Name: entré Model PD08-U Regulation Number: 21 CFR Regulation Name: Compressible Limb Sleeve Regulatory Class: Class II Product Code: JOW Dated: March 27, 2015 Received: March 30, 2015 Dear Daniel Chase, We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR
2 Page 2 - Daniel Chase Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections of the Act); 21 CFR If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) or (301) or at its Internet address Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part ). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) or (301) or at its Internet address Sincerely yours, Enclosure for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
3 DEPARTMENT OF HEALTH AND HUMAN SERVICES Indications for Use Form Approved: OMB No Expiration Date: January 31, 2017 See PRA Statement below. 510(k) Number (if known) K Device Name entré Model PD08-U Indications for Use (Describe) The entré System is intended for use by medical professionals and patients who are under medical supervision, for the treatment of the following conditions: Chronic edema Lymphedema Venous insufficiency Wound healing Type of Use (Select one or both, as applicable) Prescription Use (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C) CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: Department of Health and Human Services Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number. FORM FDA 3881 (8/14) Page 1 of 1 PSC Publishing Services (301) EF
4 510(k) Summary: K Submission Date: April 30, 2015 Submitter: Contact Person: Name of Device: Daniel G. Chase VP, Engineering and Operations Tactile Medical 1331 Tyler Street NE, Suite 200 Minneapolis, MN USA Telephone: (612) Daniel G. Chase entré Model PD08-U Classification: Compressible Limb Sleeve (21 CFR ) Predicate Devices: Petite Basic System 701 ELT (K131420) CircuFlow 5150 (K123959) CircuFlow 5208 (K123647) Device Description The entré model PD08-U system consists of two main components: A controller and a garment. The garment is to be wrapped around the affected extremity providing a snug yet comfortable fit. The garment will have eight (8) chambers that are filled with air by the controller to provide compression on the extremity. A harness assembly consisting of eight (8) individual tubes will connect individual chambers with the controller. The controller has an internal valve manifold with a directly connected single eight (8) port connector extension that is accessible to the user on the front panel allowing easy garment connection. Intended Use The entré System is intended for use by medical professionals and patients who are under medical supervision, for the treatment of the following conditions: Chronic edema Lymphedema Venous insufficiency Wound healing
5 Comparison of Technical Characteristics The entré model PD08-U system has the same technological characteristics to the predicate devices with respect to intended use, design, materials used, and construction. The device has been certified to be compliant with ANSI/AAMI ES , IEC Ed. 3, CAN/CSA C22.2 No (Medical Electrical Equipment- General require for Safety), EN (Electromagnetic Compatibility), IEC (Usability), and IEC (In-Home Medical Equipment). Test Summary The following performance testing and analysis was completed to verify the substantial equivalence between the entré model PD08-U, the subject of this submission, and the predicate devices. Garment Chamber Pressure Testing Both the entré model PD08-U and the predicate devices operate within similar pressure ranges. Pressure testing was performed to verify that the target pressures were met as stated in the device labeling. Cycle Time Testing Predicated devices and the entré model PD08-U are pressure based. Comparative cycle time data was recorded and evaluated. Both devices performed similarly and as stated in the device labeling. Additional Testing Additional non-clinical testing performed for the entré model PD08-U included: o Electromagnetic Safety (IEC :2007) o Electrical Safety (IEC :2005) Substantial Equivalence Conclusion The results from nonclinical device testing demonstrates that the entré model PD08-U system raises no new safety or effectiveness concerns and is substantially equivalent to the predicate devices for its intended use.